Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

reddit: 1 Redditor

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,718 followers.

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma https://t.co/0XVhEgqmIk

25 Sep 2023

Reply Repost Favourite

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma https://t.co/9fIbEXMHhU

25 Sep 2023

Reply Repost Favourite

RT @FrontOncology: New research: Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in he…

15 Sep 2023

Reply Repost Favourite

New research: Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma: Introduction Hepatocellular carcinoma (HCC) patients at advanced stages receive immunotherapy or… #oncology htt

15 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.